
A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in Long COVID. 45 participants used a specific transcutaneous auricular vagus nerve stimulation (taVNS) device, or a sham (placebo), during the four-week trial.

A new study in the International Journal of Infectious Diseases examines how COVID-19 impacts the immune system.

The German government is cutting millions of euros in Long COVID funding, according to the German business newspaper Handelsblatt.

The country’s pension insurance system pushes people to go through rehabilitation (“Reha”) clinics before they can access disability supports.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance